Clinical Trial Update: Triferic Pediatric Pharmacokinetic Protocol [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial update for Triferic pediatric pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Triferic (ferric pyrophosphate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: End Stage Renal Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-10-25